Search research articles
Contact Us
Filters
Showing results (121-130 of 156) with videos related to
Page
of 16
Sort By:
Heart (British Cardiac Society)
|
June 27, 2014
Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy
Tevfik F Ismail, Andrew Jabbour, Ankur Gulati, et al.
JAMA Cardiology
|
July 2, 2025
Location of LMNA Variants and Clinical Outcomes in Cardiomyopathy
Ashwin Bhaskaran, Rabah Ben Yaou, Adam S Helms, et al.
Journal of the American College of Cardiology
|
December 10, 2003
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction
Matteo Vatta, Bhagyalaxmi Mohapatra, Shinawe Jimenez, et al.
ESC Heart Failure
|
August 9, 2020
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients
Tiina Heliö, Perry Elliott, Juha W Koskenvuo, et al.
JACC. Heart Failure
|
April 26, 2025
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Ahmad Masri, Martin S Maron, Theodore P Abraham, et al.
The New England Journal of Medicine
|
September 1, 2025
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Milind Y Desai, Anjali T Owens, Theodore Abraham, et al.
European Heart Journal
|
January 11, 2022
European Society of Cardiology: cardiovascular disease statistics 2021
Adam Timmis, Panos Vardas, Nick Townsend, et al.
Circulation
|
November 23, 2022
Circulating c-Met-Expressing Memory T Cells Define Cardiac Autoimmunity
Silvia Fanti, Edward Stephenson, Etel Rocha-Vieira, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 30, 2022
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary
Adam Timmis, Panos Vardas, Nick Townsend, et al.
Journal of the American College of Cardiology
|
October 30, 2024
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
Ahmad Masri, Lubna Choudhury, Roberto Barriales-Villa, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 156) with videos related to
Sort By:
Page
of 16
Heart (British Cardiac Society)
|
June 27, 2014
Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy
Tevfik F Ismail, Andrew Jabbour, Ankur Gulati, et al.
JAMA Cardiology
|
July 2, 2025
Location of LMNA Variants and Clinical Outcomes in Cardiomyopathy
Ashwin Bhaskaran, Rabah Ben Yaou, Adam S Helms, et al.
Journal of the American College of Cardiology
|
December 10, 2003
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction
Matteo Vatta, Bhagyalaxmi Mohapatra, Shinawe Jimenez, et al.
ESC Heart Failure
|
August 9, 2020
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients
Tiina Heliö, Perry Elliott, Juha W Koskenvuo, et al.
JACC. Heart Failure
|
April 26, 2025
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy
Ahmad Masri, Martin S Maron, Theodore P Abraham, et al.
The New England Journal of Medicine
|
September 1, 2025
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Milind Y Desai, Anjali T Owens, Theodore Abraham, et al.
European Heart Journal
|
January 11, 2022
European Society of Cardiology: cardiovascular disease statistics 2021
Adam Timmis, Panos Vardas, Nick Townsend, et al.
Circulation
|
November 23, 2022
Circulating c-Met-Expressing Memory T Cells Define Cardiac Autoimmunity
Silvia Fanti, Edward Stephenson, Etel Rocha-Vieira, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
April 30, 2022
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary
Adam Timmis, Panos Vardas, Nick Townsend, et al.
Journal of the American College of Cardiology
|
October 30, 2024
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM
Ahmad Masri, Lubna Choudhury, Roberto Barriales-Villa, et al.
Page
of 16